Equivalent Systemic Exposure to Fluticasone Propionate/Salmeterol Following Single Inhaled Doses from Advair Diskus and Wixela Inhub: Results of Three Pharmacokinetic Bioequivalence Studies

Background: Wixela(®) Inhub(®) was developed to deliver inhaled fluticasone propionate/salmeterol (FP/S) combination as a substitutable generic equivalent to Advair(®) Diskus(®). These studies aimed to confirm the pharmacokinetic bioequivalence (BE) of FP/S after single doses of Wixela Inhub (test [...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Aerosol Med Pulm Drug Deliv
Autors principals: Haughie, Scott, Allan, Richard, Wood, Nolan, Ward, Jon
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc., publishers 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7041328/
https://ncbi.nlm.nih.gov/pubmed/31364911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2019.1537
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars